NasdaqGS:TXGLife Sciences
10x Genomics (TXG) Launches Cleveland Clinic Partnership For Bladder Cancer Diagnostics
10x Genomics (NasdaqGS:TXG) announced a multi-year research collaboration with Cleveland Clinic focused on bladder cancer diagnostics.
The partnership centers on using single-cell, spatial transcriptomic, and protein profiling technologies to build multimodal cancer datasets.
The collaborators plan to link molecular data with clinical outcomes, aiming to support future diagnostic applications across oncology.
10x Genomics enters this Cleveland Clinic collaboration with its stock at $31.75...